Asif Ali - 16 Jan 2023 Form 4 Insider Report for Protagonist Therapeutics, Inc (PTGX)

Role
Chief Financial Officer
Signature
/s/ Asif Ali
Issuer symbol
PTGX
Transactions as of
16 Jan 2023
Net transactions value
$0
Form type
4
Filing time
18 Jan 2023, 18:53:31 UTC
Previous filing
19 Apr 2022
Next filing
19 Apr 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PTGX Common Stock Award $0 +10,625 +77% $0.000000 24,375 16 Jan 2023 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PTGX Stock Option (right to buy) Award $0 +63,750 $0.000000 63,750 16 Jan 2023 Common Stock 63,750 $12.17 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents grant of restricted stock units payable solely in common stock that will vest in three annual installments on January 15, 2024, 2025 and 2026.
F2 The stock option vests in 48 equal monthly installments following the date of grant.